Pentaomix
Pentaomix
Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.
About
Technology stack
detected 2026-06-30No comments yet. Be the first to share your take.
What does Pentaomix do?
Pentaomix provides a solution for tumor characterization using a single pathological slide, enabling pathologists to visualize cancer by staining multiple biomarkers in one step and mapping them with a hyperspectral scanner. Their system offers AI-based decision support tools for faster diagnosis, personalized drug matching, and analysis of the tumor microenvironment, serving pathologists and medical teams. This technology helps overcome challenges like limited tissue availability and the comple…
Where is Pentaomix headquartered?
Pentaomix is headquartered in Tel Aviv, Israel.
When was Pentaomix founded?
Pentaomix was founded in 2020.
What industry does Pentaomix operate in?
Pentaomix operates in Healthcare, Pathology, Cancer Screening, Diagnostics, Drug Development, Hyperspectral.
How many employees does Pentaomix have?
Pentaomix has approximately 5 people on record.
What is Pentaomix's revenue?
StartupHub estimates Pentaomix's annual revenue at $1.6M (range $870K to $2.6M, 63% confidence), based on comparable companies in the sector.